Piper Sandler Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $16
Dentsply Sirona Analyst Ratings
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $16
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $16
Mizuho Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $16
Morgan Stanley Downgrades Dentsply Sirona(XRAY.US) to Hold Rating, Cuts Target Price to $14
Leerink Partners Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
BofA Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $16
Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (CLSD), Biogen (BIIB) and DENTSPLY SIRONA (XRAY)
Needham Downgrades Dentsply Sirona(XRAY.US) to Hold Rating
Dentsply Sirona Is Maintained at Neutral by Mizuho
Dentsply Sirona Analyst Ratings
Needham Downgrades DENTSPLY SIRONA to Hold From Buy, Removes $23 Price Target
Mizuho Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $18
Jefferies Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $17
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), DENTSPLY SIRONA (XRAY) and Cytokinetics (CYTK)
A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $19 to $27
Dentsply Sirona Is Maintained at Equal-Weight by Wells Fargo
Dentsply Sirona Price Target Cut to $20.00/Share From $22.00 by Baird
Dentsply Sirona Is Maintained at Neutral by Baird